Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q2 FY23 Earnings Presentation
57 slides from Aster Dm Healthcare's earnings presentation, Nov 10, 2022
Slide 1: Cover letter to stock exchanges
November 10, 2022 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 40005
Slide 2: Investor Presentation for the quarter ended 30th September 2022
Aster &; We'll Treat You Well INVESTOR PRESENTATION For the quarter ended 30th September 2022
Slide 3: Disclaimer
Disclaimer * This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Vision
VISION A Caring Mission with a Global Vision to Serve the World with Accessible and Affordable Quality Healthcare.
Slide 5: Aster DM Healthcare – Evolution
Aster DM Healthcare – Evolution New geographies, segments Brand “Aster” was formed, private Robust Growth across all Growth and Diversification into Building the foundations and service offerings equity investment, further expansion segments and geographies; Rapid aligned businesses across Expansion
Slide 6: Business Overview (H1)
Business Overview (H1) 30 GCC : 15 Largest Private Healthcare 5,521 GCC : 1,441 Hospitals India : 15 Capacity Beds India : 4,080 Presence in 7 Countries 121 GCC : 110 9.3 Mn GCC. : 7.8 Mn Clinics India : 11 Patient Visits India : 1.5 Mn4 459 GCC : 245 Pharmacies1 India : 2142 Largest Number of Medic
Slide 7: Geographical Footprint
6 Geographical Footprint United Arab Emirates Kingdom of Saudi Arabia Kerala Andhra Pradesh Karnataka H(9) C(96) P(222) H(1) H(6) C(2) P(65) L(5) PEC(71) H(4) C(4) L(2) H(3) C(5) P(96) L(5) PEC(65) Oman Qatar Bahrain Jordan Maharashtra Telangana Tamil Nadu C(2) P(2) H(1) L(3) PEC(3) H(1) P(53) L(1)
Slide 8: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview
Slide 9: GCC Hospitals
GCC Hospitals 8 UAE Qatar Oman Saudi
Slide 10: India Hospitals
India Hospitals 9 Kerala Cluster Andhra & Telangana Cluster Karnataka & Maharashtra Cluster
Slide 11: Hospitals: Pipeline Projects
Hospitals: Pipeline Projects Owned / Hospitals - GCC Location Planned Beds Expected Completion Year Present Status Leased/O&M Owned / Hospitals - India Location Planned Beds Expected Completion Year Present Status Leased/O&M
Slide 12: The Aster DM Healthcare Edge
The Aster DM • Healthcare Edge • Robust & • • Expansive Healthcare • Ecosystem • Synergies • • Across Geographies Sturdy • • Performance Record • • Proficient & Experienced • Management • Team Asset-Light Business Model • • De-Risked Business Model • • Touchstone of • Healthcare • Practices
Slide 13: Historical Trends
Historical Trends Capacity Beds Outpatient Count (in mn) Inpatient Count (in ‘000) ..Coupled with capacity creation for further growth # of Units FY17 FY18 FY19 FY20 FY21 FY22 FY23 H1 Hospitals 18 19 24 25 27 27 30 Clinics 96 101 114 117 115 120 121 Pharmacies - GCC 202 207 219 238 223 240 245 Pharm
Slide 14: An Integrated Healthcare Provider
AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider
Slide 15: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY22 Operational Information 1,500+ 273,000+ Cardiovascular IP Discharges Surgeries ~6.2 mn 20,500+ 1,300+ Clinic OPD Visits General Bariatric Surgeries Surgeries 2,400+ 800+ Joint ~ 8.0 mn Spine Replacements Pharmacy Surgeries Visits 13,600+ 500+ Urology Ca
Slide 16: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Patient Life Cycle Management • Hospitals Clinics Pharmacies • • GCC INDIA • • Hospitals Clinics Resource Talent Management
Slide 17: Digital Health
Digital Health ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 18: Aster Labs
ORIGIN Aster Labs was established in 2019, with one true preposition of providing THE TRUE TEST. THE TRUE TEST is the brand promise that every analysis will be most accurate —and help doctors to diagnose better and ultimately help patients recover faster. We have successfully served more than 1.6 Mi
Slide 19: GCC Healthcare – Unique traits
GCC Healthcare – Unique traits Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) ➢ ➢ ➢ ➢ ➢ Seasonality of Patient Volumes ➢ ➢ ➢ ➢ ➢ Source : World Bank (2021 data) ➢ Source: 1. english.alarabiya.net ➢ 2. worldpopulationreview.com 3. omanobserver.com 4. edsfze.com
Slide 20: Aster Pharmacies India – Current Status and Way Forward
(INDIA) ◼ Current Status ◼ ◼ ◼ ◼ ◼ ◼ Forward Way ◼ ◼ *214 pharmacies in India operated by ARPPL under brand license from Aster
Slide 21: Aster - Awards & Service Excellence
Aster - Awards & Service Excellence 20 Dr. Azad Moopen • Alisha Moopen • • • • • • • • • • 6 JCI Accredited Aster Hospital Mankhool, “Saudi Central Board for Qusais and Day Care Accreditation for Healthcare Surgery Centre in UAE Institutions (CBAHI)” HIMMS Accreditation JCI Accredited (Stage 6) Aste
Slide 22: Aster - Awards
Aster - Awards Times All India Multispecialty Outlook's Best Hospital Ranking UAE Innovation Award Hospitals Ranking Survey 2021 2022 Aster Medcity Aster CMI, MIMS Calicut and Aster RV Dubai Quality Award IHF LinkedIn Aster Top 5 DQA - DQAA Dubai Service Excellence ICC Healthcare Excellence Awards T
Slide 23: Aster - Awards
Aster - Awards Asian Hospital Middle East Technology Cyber Security Council Management Awards Excellence Awards Arabia Corporate Social Excellence in therapeutic food World AI Show & Awards – Responsibility Awards service management Best Project Implementation (AI Case Award) DNV Accreditation – Ort
Slide 24: Operational and Financial Overview
OPERATIONAL AND FINANCIAL OVERVIEW Operational and Financial Overview
Slide 25: Clinical Highlights - FY23 Q2
Clinical Highlights - FY23 Q2 India ➢ ➢ ➢ ➢ ➢ GCC ➢ ➢ ➢ ➢ ➢
Slide 26: Revenue and Profitability Snapshot – FY23 Q2
Revenue and Profitability Snapshot – FY23 Q2 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Revenue excluding new hospitals4 is Rs. ▪ EBITDA excluding new hospitals4 is Rs. ▪ PAT (Post-NCI) excluding new hospitals4 2,796 Crs. (Growth of 12 %) 342 Crs. (Neutral compared to FY22
Slide 27: Revenue and Profitability Snapshot – FY23 H1
Revenue and Profitability Snapshot – FY23 H1 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Revenue excluding new hospitals4 is ▪ EBITDA excluding new hospitals4 is Rs. ▪ PAT (Post-NCI) excluding new Rs. 5,450 Crs. (Growth of 12 %) 654 Crs. (Growth of 5 %) hospitals and one-tim
Slide 28: Geography – wise Financial Snapshot – Quarterly
Geography – wise Financial – Snapshot – Quarterly GCC INDIA CONSOLIDATED FY22 Q2 FY23 Q2 Gw (%) FY22 Q2 FY23 Q2 Gw (%) FY22 Q2 FY23 Q2 Gw (%) Revenue (₹) EBITDA (₹) PAT (Post-NCI) (₹) ➢ ➢
Slide 29: Geography – wise Financial Snapshot – Half-Yearly
Geography – wise Financial – Snapshot – Half-Yearly GCC INDIA CONSOLIDATED FY22 H1 FY23 H1 Gw (%) FY22 H1 FY23 H1 Gw (%) FY22 H1 FY23 H1 Gw (%) Revenue (₹) EBITDA (₹) PAT (Post-NCI) (₹) ➢ ➢
Slide 30: Geography – wise Business Snapshot - Quarterly
Geography – wise Business – Snapshot - Quarterly GCC INDIA CONSOLIDATED FY22 Q2 FY23 Q2 FY22 Q2 FY23 Q2 FY22 Q2 FY23 Q2 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visits In-patient visits ARPOBD (INR)
Slide 31: Geography – wise Business Snapshot – Half Yearly
Geography – wise Business – Snapshot – Half Yearly GCC INDIA CONSOLIDATED FY22 H1 FY23 H1 FY22 H1 FY23 H1 FY22 H1 FY23 H1 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatient Visits In-patient visits ARPOBD (INR)
Slide 32: Geography – wise Business Snapshot – Quarterly (India clusters)
Geography – wise Business – Snapshot – Quarterly KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY22 Q2 FY23 Q2 FY22 Q2 FY23 Q2 FY22 Q2 FY23 Q2 FY22 Q2 FY23 Q2 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpatien
Slide 33: Geography – wise Business Snapshot – Half Yearly (India clusters)
Geography – wise Business – Snapshot – Half Yearly KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY22 H1 FY23 H1 FY22 H1 FY23 H1 FY22 H1 FY23 H1 FY22 H1 FY23 H1 Total Capacity Beds Operational Beds (Census) Operational Beds (Non-Census) Available Capacity Beds ALOS (Days) Occupancy Outpati
Slide 34: Segmental Performance FY23 Q2
India - India - Labs Unallocated India - India - Labs Unallocated GCC GCC GCC GCC FY23 Q2 GCC Clinics Hospitals & & Wholesale & Total GCC Clinics Hospitals & & Wholesale & Total Hospitals Pharmacies Hospitals Pharmacies Clinics Pharmacy Eliminations Clinics Pharmacy Eliminations No. of Business Unit
Slide 35: Segmental Performance FY23 H1
Segmental Performance FY23 H1 India - Labs India - Labs India - Unallocated India - Unallocated GCC GCC & GCC GCC & FY23 H1 GCC Clinics Hospitals & & Total GCC Clinics Hospitals & & Total Hospitals Pharmacies Wholesale Hospitals Pharmacies Wholesale Clinics Eliminations Clinics Eliminations Pharmacy
Slide 36: Maturity Wise Hospital Performance – GCC FY23 H1
Maturity Wise Hospital Performance – GCC FY23 H1 ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 37: Maturity Wise Hospital Performance – India FY23 H1
Maturity Wise Hospital Performance – India FY23 H1 ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 38: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY23 Q1 FY22 Q2 FY23 Q2 Y-o-Y Gw% Q-o-Q Gw% Revenue from operations 2,662 2,504 2,816 12% 6% Material consumption 812 728 839 Doctors cost 560 500 597 Employee cost (excl. doctors) 607 502 650 Laboratory outsourcing charges 16 63
Slide 39: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY22 H1 FY23 H1 Gw% Revenue from operations 4,876 5,478 12% Material consumption 1,442 1,651 Doctors cost 982 1,158 Employee cost (excl. doctors) 964 1,257 Laboratory outsourcing charges 136 35 Other expenses 728 767 EBITDA (excl
Slide 40: Financial Summary – Balance Sheet & Ratios
Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Sep 30, As at Mar 31, As at Sep 30, Particulars (INR Cr) Consolidated (INR Cr) 2022 2022 2022 2022 LIABILITIES Gross Debt 2,192 2,329 Shareholders Equity 3,953 4,147 Less: Cash, Bank Balance and Current Investments 386 284 Minority Inter
Slide 41: Consol Trends - I
Consol Trends - | Revenue (INR Cr) EBITDA 1,483 10,253 1,258 8,652 8,608 i 1,063 : FY20 FY21. FY22 FY23 H1 FY20 FY21 FY22 FY23H1 EBITDA Margin ROCE 9.7% 8.6% 14.5% 14.5% 11.2% 7.4% [PY H1: 12.8%] 5.1% FY20 FY21 FY22 FY23 H1 FY20 FY21 FY22 FY23 TTM EBITDA numbers are Post IndAS116 FY21 numbers have a
Slide 42: Consol Trends - II
Consol Trends - Il Net Debt (excl. Lease Liabilities) (INR Cr) 2,784 2,004 2,045 1,806 FY20 FY21 FY22 FY23 H1 Net Debt (incl. Lease Liabilities) (INR Cr) ened 4,978 4,498 4,521 ° FY20 FY21 FY22 FY23H1 Net Debt (excl. Lease Liabilities)/EBITDA 2.9 27 1.6 19 FY20 Fy21 FyY22 FY23TTM * Post IndAS 116 FY
Slide 43: India: Financial Trends
India: Financial Trends 42 Revenue EBITDA 2384 353 1631 1654 183 144 FY20 FY21 Fv22 FY23 H1 FY20 Fy21 FY22 FY23 HL EBITDA Margin ROCE 15.0% 1a,8% | (PYH4: 15.0%) 12% 8.0% 11.3% 8.7% 1.6% 0.0% Fy20 Fy21 Fy22 0 FY23 H1 FY20 FY21 FY22.—«FY23TTM
Slide 44: India Hospital & Clinics Cluster-Wise Trends
India Hospital & Clinics Cluster-Wise Trends
Slide 45: Strategy & Leadership
STRATEGY & LEADERSHIP Strategy & Leadership
Slide 46: GCC Strategy
GCC Strategy The pandemic allowed us to reflect and re- invent certain processes at all the locations. Enhanced use of digital means made us explore the power of digitization. We have launched Aster Digital Initiative with a strong focus on foundational and growth levers. Initiatives like Virtual Ca
Slide 47: India Strategy
India Strategy Aster DM Hospitals consistently amongst the top in google rankings and patient endorsements – Visibly growing appreciation in India for quality healthcare, clinical excellence and patient service
Slide 48: ESG: Committed to UN Sustainable Development Goals
ESG: Committed to UN Sustainable Development Goals
Slide 49: ESG highlights for the year
ESG highlights for the year In this financial year we have made significant progress on all aspects of E: Environment, S: Social and G: Governance performance 1,993 MWh energy consumption reduction n x across Aster Hospitals GCC fg 268,983 KL of water saved by recycling Environment a2 100% Resolutio
Slide 50: Aster’s ESG Materiality Assessment
Aster’s ESG Materiality Assessment
Slide 51: Aster’s commitment to UNSDG
Aster’s commitment to UNSDG The 17 Sustainable Development Goals are considered as the blueprint to achieve a sustainable future for all, it is important that we all work together to achieve them by 2030. At Aster, we have identified the goals relevant to our operations, and we are working towards t
Slide 52: Aster’s alignment with SASB to focus on material issues
Aster’s alignment with SASB to focus on material issues
Slide 53: Aster DM Healthcare - ESG update under each pillar
Aster DM Healthcare - ESG update under each pillar ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 54: Aster – ESG Strategy
Aster – ESG Strategy Current ESG practices External engagement for gap ESG Policy and ESG Risk ESG Pillars identified in assessment of Aster’s framework approved by the Board level ESG commitment Sustainability Report Aster Board sustainability report against global frameworks Next steps ▪ ▪ ▪ ▪ ▪ ▪
Slide 55: Aster Leadership Team
Aster Leadership Team Dr. Azad Moopen T. J. Wilson Fara Siddiqi Alisha Moopen Sreenath Reddy Dr. Malathi Veneeth Purushotaman Amitabh Johri Brandon Rowberry Daniel Whitehead Dr. Shanila Laiju Dr. Sherbaz Bichu Bala NS Farhan Yasin Dr. Nitesh Shetty Devanand K T Sunil Kumar M R Anindya Chowdhury Rama
Slide 56: Aster Board of Directors
Aster Board of Directors Dr. Azad Moopen Alisha Moopen T. J. Wilson Anoop Moopen Shamsudheen Bin Daniel Robert Prof. Biju Varkkey Sridar Arvamudhan Mohideen Mammu Haji Mintz Iyengar Dr. Layla Mohamed Chenayappillil John James Mathew Wayne Earl Hassan Ali Al Marzooqi George Keathley
Slide 57: Thank You
Aster We'll Treat You Well Thank You www.asterdmhealthcare.com Email: investors@asterdmhealthcare.com